help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sudhaker Rao, D.
Right arrow Articles by Parfitt, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sudhaker Rao, D.
Right arrow Articles by Parfitt, A. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 5 2328
Copyright © 2001 by The Endocrine Society

Letters to the Editor

Vitamin D Receptor Status in Parathyroid Adenomasc

D. Sudhaker Rao

A. Michael Parfitt

Bone and Mineral Metabolism Henry Ford Health System Detroit, Michigan 48202-2689
Division of Endocrinology University of Arkansas Little Rock, Arkansas 72205-7199

To the editor:

We are pleased to learn that our initial finding of loss of vitamin D receptor in parathyroid adenomas by immunohistochemistry (1, 2) has now been confirmed by independent investigators looking at vitamin D receptor messenger RNA (3).

They cite our study showing the inverse relationship between serum 25-hydroxyvitamin D level and parathyroid gland weight (4). However, they misquoted our findings. We found no correlation between serum 1,25-dihydroxyvitamin D levels and parathyroid gland weight.

Footnotes

c Received June 28, 2000. Address correspondence to: D. Sudhaker Rao, M.D., Bone and Mineral Metabolism, Department of Internal Medicine, Henry Ford Health System, 2799 West Grand Boulevard, Room E-1607, Detroit, Michigan 48202-2689.

References

  1. Rao D, Han Z-H, Phillips E, Palnitkar S, Parfitt A. 1997 Loss of calcitriol receptor expression in parathyroid adenomas: implications for pathogenesis (Abstract). J Bone Miner Res. 12:S107.
  2. Rao D, Han Z-H, Phillips E, Palnitkar S, Parfitt A. 2000 Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis. Clin Endocrinol 53:373–381.
  3. Carling T, Rastad J, Szabo E, Westin G, Akerstrom G. 2000 Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab. 85:2000–2003.[Abstract/Free Full Text]
  4. Rao D, Honasoge M, Divine G, et al. 2000 Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab,85 :1054–1058.




This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sudhaker Rao, D.
Right arrow Articles by Parfitt, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sudhaker Rao, D.
Right arrow Articles by Parfitt, A. M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals